FDA approval is a critical regulatory milestone that often leads to an increase in a company's stock price due to the potential for new revenue streams and market expansion. Given that this approval allows CorMedix to market Defencath in the US, it is highly relevant and important to the company's prospects. The confidence in this analysis is high due to the direct correlation between FDA approvals and positive market perception.